Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Comella

Showing results (91-100 of 684) with videos related to

Pageof 69
Sort By:
Oncology|January 7, 2004
Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naïve non-small cell lung cancer patientsGiuseppe Frasci, Pasquale Comella, Giuseppe De Cataldis, et al.
Tumori|April 25, 2000
Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: an effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma. A multicenter phase II study of the Southern Italy Cooperative Oncology GroupP Comella, V Lorusso, R Casaretti, et al.
Seminars in Oncology|August 18, 2001
Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II studyG Frasci, G D'Aiuto, P Comella, et al.
Psychosomatics|August 26, 2018
Progressive Encephalomyelitis With Rigidity and Myoclonus Syndrome Presenting as CatatoniaNatalie Witek, Charles Hebert, Anjali Gera, et al.
The Oncologist|November 7, 1999
Is there any impact of new drugs on the outcome of advanced NSCLC? An overview of the Southern Italy Cooperative Oncology Group trialsG Frasci, N Panza, G Comella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 27, 2011
Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trialJoseph Jankovic, Cynthia Comella, Angelika Hanschmann, et al.
Neurologia (Barcelona, Spain)|January 1, 1990
[The neuromuscular junction: morphofunctional correlation]J E Esquerda, J Ribera, J X Comella
Journal of Clinical Medicine|March 14, 2026
Factors Influencing SVF Yields from Human Adipose Tissue: Isolation Technique, Age, and SexSarah Regener, Elijah Joy, Kristin Comella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Extensor truncal dystonia: successful treatment with botulinum toxin injectionsC L Comella, K M Shannon, J Jaglin
Journal of Bacteriology|July 24, 2001
Control of a family of phosphatase regulatory genes (phr) by the alternate sigma factor sigma-H of Bacillus subtilisR S McQuade, N Comella, A D Grossman
Pageof 69

Showing results (91-100 of 684) with videos related to

Sort By:
Pageof 69
Oncology|January 7, 2004
Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naïve non-small cell lung cancer patientsGiuseppe Frasci, Pasquale Comella, Giuseppe De Cataldis, et al.
Tumori|April 25, 2000
Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: an effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma. A multicenter phase II study of the Southern Italy Cooperative Oncology GroupP Comella, V Lorusso, R Casaretti, et al.
Seminars in Oncology|August 18, 2001
Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II studyG Frasci, G D'Aiuto, P Comella, et al.
Psychosomatics|August 26, 2018
Progressive Encephalomyelitis With Rigidity and Myoclonus Syndrome Presenting as CatatoniaNatalie Witek, Charles Hebert, Anjali Gera, et al.
The Oncologist|November 7, 1999
Is there any impact of new drugs on the outcome of advanced NSCLC? An overview of the Southern Italy Cooperative Oncology Group trialsG Frasci, N Panza, G Comella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 27, 2011
Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trialJoseph Jankovic, Cynthia Comella, Angelika Hanschmann, et al.
Neurologia (Barcelona, Spain)|January 1, 1990
[The neuromuscular junction: morphofunctional correlation]J E Esquerda, J Ribera, J X Comella
Journal of Clinical Medicine|March 14, 2026
Factors Influencing SVF Yields from Human Adipose Tissue: Isolation Technique, Age, and SexSarah Regener, Elijah Joy, Kristin Comella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Extensor truncal dystonia: successful treatment with botulinum toxin injectionsC L Comella, K M Shannon, J Jaglin
Journal of Bacteriology|July 24, 2001
Control of a family of phosphatase regulatory genes (phr) by the alternate sigma factor sigma-H of Bacillus subtilisR S McQuade, N Comella, A D Grossman
Pageof 69